Autism Spectrum Disorder Trial, Recruiting (NCT06627205)

Autism Spectrum Disorder Trial, Recruiting NCT06627205 Sponsor: Stanford University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06627205 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your child has been diagnosed with autism spectrum disorder, confirmed through medical records and recognized diagnostic tests
Your child has sleep problems, identified through a clinical interview and a sleep questionnaire score above a certain level
Your child has been on the same medications for at least 2 weeks before the study begins
There are no plans to change your child's therapy or medical treatments during the study period
A parent or guardian who speaks English is able to take part in the study consistently
Your family lives in California, USA

Who may not be able to join:

The parent or child has been diagnosed with a serious psychiatric condition or has an unstable medical problem
The child has active seizures or epilepsy
The child's main sleep problem is related to their internal body clock being out of sync (such as always falling asleep or waking at unusual times), as identified through interview and a questionnaire (confirm with trial site)
The child is currently receiving, or has already completed, a full course of a therapy called sleep restriction therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emma K Baker, MPsych(Clin), PhD, Stanford University

Phone: 6507361235

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06627205

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 6507361235

More information: https://clinicaltrials.gov/study/NCT06627205

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your child has been diagnosed with autism spectrum disorder, confirmed through medical records and recognized diagnostic tests
Your child has sleep problems, identified through a clinical interview and a sleep questionnaire score above a certain level
Your child has been on the same medications for at least 2 weeks before the study begins
There are no plans to change your child's therapy or medical treatments during the study period
A parent or guardian who speaks English is able to take part in the study consistently
Your family lives in California, USA

Who may not be able to join:

The parent or child has been diagnosed with a serious psychiatric condition or has an unstable medical problem
The child has active seizures or epilepsy
The child's main sleep problem is related to their internal body clock being out of sync (such as always falling asleep or waking at unusual times), as identified through interview and a questionnaire (confirm with trial site)
The child is currently receiving, or has already completed, a full course of a therapy called sleep restriction therapy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

11 February 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability of Sleep Restriction Therapy; Tolerability of Sleep Restriction Therapy; Feasibility of Sleep Restriction Therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov